MedPath

To evaluate the effect of virechana (purgation) and varunadi ghan vati on Poly cystic ovarian syndrome.

Phase 2
Conditions
Health Condition 1: E282- Polycystic ovarian syndrome
Registration Number
CTRI/2022/08/044876
Lead Sponsor
niversity Post Graduate Institute of Ayurved Studies and Research Jodhpur Rajasthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients diagnosed cases of PCOS by the Rotterdam criteria

2.Age: Patients aged between 16-40 years.

3.The patients who are fit for the virechana procedure were only considered for The study.

4.Patients willing for Informed consent.

Exclusion Criteria

1.Known congenital adrenal hyperplasia, androgen secreting tumors were excluded which also present the complaints of oligomenorrhea or irregular cycles and anovulation.

2.Other endocrinal disorders like Cushingââ?¬•s syndrome were excluded as they also precipitate the pathology of PCOS.

3.The patients with BMI > 30 are considered to be morbidly obese and are not fit for the panchakarma procedures. Hence they were not considered for the study.

4.The patients suffering with rectal pathologies like fissure, fistulas were excluded.

5.The patients who were unfit for virechana procedure were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in ovarian size ,volume ,stromal pattern , and in menstrual irregularities.Timepoint: 60 days
Secondary Outcome Measures
NameTimeMethod
Improvement in FBS , lipid profile , BMI ,WHR Ratio ,and on acne , Hirsutism.Timepoint: 60 days
© Copyright 2025. All Rights Reserved by MedPath